HEADER LIGASE 13-NOV-25 9T8Y TITLE CRYSTAL STRUCTURE OF BETA-TRCP BOUND BY MONOPHOSPHORYLATED NRF2 DEGRON TITLE 2 PEPTIDE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: F-BOX/WD REPEAT-CONTAINING PROTEIN 1A; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: E3RSIKAPPAB,EPIDIDYMIS TISSUE PROTEIN LI 2A,F-BOX AND WD COMPND 5 REPEATS PROTEIN BETA-TRCP,PIKAPPABALPHA-E3 RECEPTOR SUBUNIT; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: NF-E2-RELATED FACTOR 2,NFE2-RELATED FACTOR 2,NRF-2,NUCLEAR COMPND 12 FACTOR,ERYTHROID DERIVED 2,LIKE 2; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTRC, BTRCP, FBW1A, FBXW1A; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: NFE2L2, NRF2; SOURCE 13 EXPRESSION_SYSTEM: SYNTHETIC CONSTRUCT; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 32630 KEYWDS BETA-TRCP, E3 LIGASE, PHOSPHODEGRON, NRF2, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR G.W.COLLIE REVDAT 1 08-APR-26 9T8Y 0 JRNL AUTH D.H.O DONOVAN,J.WINTER-HOLT,G.W.COLLIE,M.E.CUOMO, JRNL AUTH 2 D.J.MCGARRY,M.FOX,B.K.ALEX SEONG,U.GRAZINI,P.BARTON, JRNL AUTH 3 D.LONGMIRE,A.LISTER,Y.XU,H.MAK,E.J.BARREY, JRNL AUTH 4 M.ACEBRON-GARCIA-DE-EULATE,M.RICHTER,N.PETER,M.COUTURIER, JRNL AUTH 5 G.J.GUTIERREZ,R.GUILBERT,W.LEE,P.A.LOCHHEAD,A.ARGYROU JRNL TITL TARGETING THE INTERACTION OF NRF2 AND BETA-TRCP WITH JRNL TITL 2 MOLECULAR GLUES JRNL REF ACS CHEM.BIOL. 2026 JRNL REFN ESSN 1554-8937 JRNL DOI 10.1021/ACSCHEMBIO.5C01006 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 75.66 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 62.8 REMARK 3 NUMBER OF REFLECTIONS : 19413 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 948 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.93 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 7.02 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2927 REMARK 3 BIN FREE R VALUE : 0.5197 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 20 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2857 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 186 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.91390 REMARK 3 B22 (A**2) : 1.38300 REMARK 3 B33 (A**2) : -2.29690 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.240 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.293 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.224 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.268 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.219 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.901 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2920 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3952 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1034 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 494 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2920 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 383 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2492 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.04 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.73 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9T8Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-NOV-25. REMARK 100 THE DEPOSITION ID IS D_1292152139. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAY-24 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95373 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19413 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.795 REMARK 200 RESOLUTION RANGE LOW (A) : 75.662 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.99 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 19% PEG3350, 0.1 M PCTP PH 6.2, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.45800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.66250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.54500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.66250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.45800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 23.54500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 184 REMARK 465 SER A 185 REMARK 465 LYS A 218 REMARK 465 ASN A 219 REMARK 465 LYS A 220 REMARK 465 PRO A 221 REMARK 465 PRO A 222 REMARK 465 ASP A 223 REMARK 465 GLY A 224 REMARK 465 ASN A 225 REMARK 465 ALA A 226 REMARK 465 GLU A 265 REMARK 465 THR A 266 REMARK 465 ASN A 548 REMARK 465 ASN B 340 REMARK 465 ASP B 341 REMARK 465 ASN B 349 REMARK 465 THR B 350 REMARK 465 SER B 351 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 191 CG CD CE NZ REMARK 470 GLN A 241 CG CD OE1 NE2 REMARK 470 ARG A 263 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 441 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 504 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 287 5.02 86.67 REMARK 500 ASP A 316 -154.56 -137.11 REMARK 500 HIS A 345 -60.35 -148.74 REMARK 500 ALA A 349 130.80 -35.09 REMARK 500 ASN A 356 145.62 -176.09 REMARK 500 ASP A 366 1.37 -69.21 REMARK 500 ALA A 392 138.85 -39.44 REMARK 500 ASP A 440 80.29 31.87 REMARK 500 ARG A 441 -15.99 75.71 REMARK 500 ASP A 479 -150.22 -132.16 REMARK 500 GLU A 517 -45.99 -137.19 REMARK 500 ASP A 538 2.47 -66.49 REMARK 500 REMARK 500 REMARK: NULL DBREF 9T8Y A 186 548 UNP Q9Y297 FBW1A_HUMAN 222 584 DBREF 9T8Y B 340 351 UNP Q16236 NF2L2_HUMAN 340 351 SEQADV 9T8Y GLY A 184 UNP Q9Y297 EXPRESSION TAG SEQADV 9T8Y SER A 185 UNP Q9Y297 EXPRESSION TAG SEQADV 9T8Y GLU A 188 UNP Q9Y297 LEU 224 ENGINEERED MUTATION SEQADV 9T8Y GLU A 192 UNP Q9Y297 LEU 228 ENGINEERED MUTATION SEQRES 1 A 365 GLY SER GLY MET GLU TRP LYS LYS GLU ILE GLU ARG MET SEQRES 2 A 365 VAL ARG THR ASP SER LEU TRP ARG GLY LEU ALA GLU ARG SEQRES 3 A 365 ARG GLY TRP GLY GLN TYR LEU PHE LYS ASN LYS PRO PRO SEQRES 4 A 365 ASP GLY ASN ALA PRO PRO ASN SER PHE TYR ARG ALA LEU SEQRES 5 A 365 TYR PRO LYS ILE ILE GLN ASP ILE GLU THR ILE GLU SER SEQRES 6 A 365 ASN TRP ARG CYS GLY ARG HIS SER LEU GLN ARG ILE HIS SEQRES 7 A 365 CYS ARG SER GLU THR SER LYS GLY VAL TYR CYS LEU GLN SEQRES 8 A 365 TYR ASP ASP GLN LYS ILE VAL SER GLY LEU ARG ASP ASN SEQRES 9 A 365 THR ILE LYS ILE TRP ASP LYS ASN THR LEU GLU CYS LYS SEQRES 10 A 365 ARG ILE LEU THR GLY HIS THR GLY SER VAL LEU CYS LEU SEQRES 11 A 365 GLN TYR ASP GLU ARG VAL ILE ILE THR GLY SER SER ASP SEQRES 12 A 365 SER THR VAL ARG VAL TRP ASP VAL ASN THR GLY GLU MET SEQRES 13 A 365 LEU ASN THR LEU ILE HIS HIS CYS GLU ALA VAL LEU HIS SEQRES 14 A 365 LEU ARG PHE ASN ASN GLY MET MET VAL THR CYS SER LYS SEQRES 15 A 365 ASP ARG SER ILE ALA VAL TRP ASP MET ALA SER PRO THR SEQRES 16 A 365 ASP ILE THR LEU ARG ARG VAL LEU VAL GLY HIS ARG ALA SEQRES 17 A 365 ALA VAL ASN VAL VAL ASP PHE ASP ASP LYS TYR ILE VAL SEQRES 18 A 365 SER ALA SER GLY ASP ARG THR ILE LYS VAL TRP ASN THR SEQRES 19 A 365 SER THR CYS GLU PHE VAL ARG THR LEU ASN GLY HIS LYS SEQRES 20 A 365 ARG GLY ILE ALA CYS LEU GLN TYR ARG ASP ARG LEU VAL SEQRES 21 A 365 VAL SER GLY SER SER ASP ASN THR ILE ARG LEU TRP ASP SEQRES 22 A 365 ILE GLU CYS GLY ALA CYS LEU ARG VAL LEU GLU GLY HIS SEQRES 23 A 365 GLU GLU LEU VAL ARG CYS ILE ARG PHE ASP ASN LYS ARG SEQRES 24 A 365 ILE VAL SER GLY ALA TYR ASP GLY LYS ILE LYS VAL TRP SEQRES 25 A 365 ASP LEU VAL ALA ALA LEU ASP PRO ARG ALA PRO ALA GLY SEQRES 26 A 365 THR LEU CYS LEU ARG THR LEU VAL GLU HIS SER GLY ARG SEQRES 27 A 365 VAL PHE ARG LEU GLN PHE ASP GLU PHE GLN ILE VAL SER SEQRES 28 A 365 SER SER HIS ASP ASP THR ILE LEU ILE TRP ASP PHE LEU SEQRES 29 A 365 ASN SEQRES 1 B 12 ASN ASP SER ASP SEP GLY ILE SER LEU ASN THR SER MODRES 9T8Y SEP B 344 SER MODIFIED RESIDUE HET SEP B 344 10 HETNAM SEP PHOSPHOSERINE HETSYN SEP PHOSPHONOSERINE FORMUL 2 SEP C3 H8 N O6 P FORMUL 3 HOH *186(H2 O) HELIX 1 AA1 MET A 187 ASP A 200 1 14 HELIX 2 AA2 ASP A 200 GLY A 211 1 12 HELIX 3 AA3 PRO A 228 GLY A 253 1 26 HELIX 4 AA4 LEU A 497 ASP A 502 1 6 HELIX 5 AA5 PRO A 506 THR A 509 5 4 SHEET 1 AA1 4 SER A 256 HIS A 261 0 SHEET 2 AA1 4 THR A 540 ASP A 545 -1 O ASP A 545 N SER A 256 SHEET 3 AA1 4 GLN A 531 SER A 536 -1 N ILE A 532 O TRP A 544 SHEET 4 AA1 4 VAL A 522 PHE A 527 -1 N GLN A 526 O VAL A 533 SHEET 1 AA2 4 VAL A 270 TYR A 275 0 SHEET 2 AA2 4 LYS A 279 LEU A 284 -1 O GLY A 283 N CYS A 272 SHEET 3 AA2 4 ILE A 289 ASP A 293 -1 O TRP A 292 N ILE A 280 SHEET 4 AA2 4 CYS A 299 LEU A 303 -1 O LYS A 300 N ILE A 291 SHEET 1 AA3 4 VAL A 310 TYR A 315 0 SHEET 2 AA3 4 VAL A 319 SER A 324 -1 O ILE A 321 N GLN A 314 SHEET 3 AA3 4 THR A 328 ASP A 333 -1 O TRP A 332 N ILE A 320 SHEET 4 AA3 4 MET A 339 ILE A 344 -1 O LEU A 343 N VAL A 329 SHEET 1 AA4 4 VAL A 350 ASN A 356 0 SHEET 2 AA4 4 MET A 359 SER A 364 -1 O VAL A 361 N ARG A 354 SHEET 3 AA4 4 ILE A 369 SER A 376 -1 O TRP A 372 N MET A 360 SHEET 4 AA4 4 ASP A 379 LEU A 386 -1 O THR A 381 N ASP A 373 SHEET 1 AA5 4 VAL A 393 PHE A 398 0 SHEET 2 AA5 4 TYR A 402 SER A 407 -1 O VAL A 404 N ASP A 397 SHEET 3 AA5 4 THR A 411 ASN A 416 -1 O TRP A 415 N ILE A 403 SHEET 4 AA5 4 PHE A 422 ASN A 427 -1 O LEU A 426 N ILE A 412 SHEET 1 AA6 4 ILE A 433 ARG A 439 0 SHEET 2 AA6 4 LEU A 442 SER A 447 -1 O GLY A 446 N ALA A 434 SHEET 3 AA6 4 ILE A 452 ASP A 456 -1 O ARG A 453 N SER A 445 SHEET 4 AA6 4 ALA A 461 LEU A 466 -1 O LEU A 466 N ILE A 452 SHEET 1 AA7 4 VAL A 473 PHE A 478 0 SHEET 2 AA7 4 ARG A 482 ALA A 487 -1 O VAL A 484 N ARG A 477 SHEET 3 AA7 4 LYS A 491 ASP A 496 -1 O TRP A 495 N ILE A 483 SHEET 4 AA7 4 CYS A 511 VAL A 516 -1 O LEU A 515 N ILE A 492 LINK C ASP B 343 N SEP B 344 1555 1555 1.33 LINK C SEP B 344 N GLY B 345 1555 1555 1.34 CRYST1 44.916 47.090 151.325 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022264 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021236 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006608 0.00000 CONECT 2825 2831 CONECT 2831 2825 2832 CONECT 2832 2831 2833 2835 CONECT 2833 2832 2834 CONECT 2834 2833 2837 CONECT 2835 2832 2836 2841 CONECT 2836 2835 CONECT 2837 2834 2838 2839 2840 CONECT 2838 2837 CONECT 2839 2837 CONECT 2840 2837 CONECT 2841 2835 MASTER 277 0 1 5 28 0 0 6 3043 2 12 30 END